Objective: We sought to identify risk factors for venous thromboembolism (VTE) among patients undergoing bariatric surgery in Michigan. Background: VTE remains a major source of morbidity and mortality after bariatric surgery. It is unclear which factors should be used to identify patients at high risk for VTE. Methods: The Michigan Bariatric Surgery Collaborative maintains a prospective clinical registry of bariatric surgery patients. For this study, we identified all patients undergoing primary bariatric surgery between June 2006 and April 2011 and determined rates of VTE. Potential risk factors for VTE were analyzed using a hierarchical logistic regression model, accounting for clustering of patients within hospitals. Significant risk factors were used to develop a risk calculator for development of VTE after bariatric surgery. Results: Among 27,818 patients who underwent bariatric surgery during the study period, 93 patients (0.33%) experienced a VTE complication, including 51 patents with pulmonary embolism. There were 8 associated deaths. Significant risk factors included previous history of VTE (OR 4.15 (OR 3.50,. Nearly 97% of patients had a predicted VTE risk less than 1%. Conclusions: In this population-based study, overall VTE rates were low among patients undergoing bariatric surgery. The use of an empirically based risk calculator will allow for the development of a risk-stratified approach to VTE prophylaxis. (Ann Surg 2012;255:1100-1104 
leading causes of mortality after weight loss procedures. [11] [12] [13] Given the significant VTE risk in these patients, both the American Society for Metabolic and Bariatric Surgery and the American College of Chest Physicians have recommended that some form of chemoprophylaxis be administered to all bariatric surgery patients in the absence of contraindications. 14, 15 Although most agree that routine VTE prophylaxis is warranted in all bariatric surgery patients, there is little evidence to support a risk-stratified approach to VTE prevention. In particular, it is unclear which patients should be targeted for more aggressive thromboprophylaxis (such as extended chemoprophylaxis) due to an increased risk for VTE. Those risk factors, alone or in combination, that are sufficient to characterize a patient as high risk have not been well established.
In this study, we performed risk-adjusted analysis from a prospective, statewide clinical registry to identify significant risk factors for VTE after bariatric surgery and to develop a preoperative risk calculator on the basis of those factors.
METHODS

Study Population
Our study is based on analysis of data from the Michigan Bariatric Surgery Collaborative (MBSC), a payer-funded quality improvement program that administers a prospective, externally audited clinical outcomes registry. The MBSC, a consortium of 32 Michigan hospitals and 79 surgeons, has been described in detail elsewhere. 16 The MBSC currently enrolls about 6000 patients annually into its registry and captures data on nearly all patients undergoing bariatric surgery in Michigan. Participating hospitals submit data on all patients who undergo primary and revisional bariatric procedures, including gastric bypass, adjustable gastric banding, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch. The registry also includes bariatric operations performed on an outpatient basis.
Patient data for the clinical registry are obtained from chart abstraction at the end of the perioperative period (in-hospital and up to 30 days after surgery) and include information on preoperative clinical characteristics and comorbid conditions, as well as perioperative clinical care and outcomes. The medical records are reviewed by centrally trained data abstractors using a standardized and validated instrument. Each hospital within the MBSC is audited annually by nurses from the coordinating center to verify the accuracy and completeness of its registry data. For this study, we identified all patients undergoing a primary (nonrevisional) bariatric surgical procedure between June 2006 and April 2011. and comorbid conditions. The height and weight were used to calculate body mass index (BMI), a ratio of the weight in kilograms to the height in meters squared. The definitions for most comorbidities included documentation of the condition and its treatment in the medical record. Comorbid conditions included pulmonary disease (asthma, obstructive/restrictive disorders, home oxygen use, Pickwickian syndrome), cardiovascular disease (coronary artery disease, dysrhythmia, peripheral vascular disease, stroke, hypertension, hyperlipidemia), sleep apnea, psychological disorders, prior VTE, diabetes, chronic renal failure (requiring dialysis or transplant), liver disease (nonalcoholic fatty liver, cirrhosis, liver transplantation), urinary incontinence, gastroesophageal reflux disease, peptic ulcer disease, cholelithiasis, previous ventral hernia repair, and musculoskeletal disorders. Collected data also include perioperative process measures, such as method of VTE prophylaxis, surgical approach (open or laparoscopic), and operative time (from incision to closure), as well as 30-day complications.
Statistical Analysis
The primary outcome for this study was the occurrence of any VTE event (clinical diagnosis of DVT or PE) within 30 days of the procedure. Potential risk factors for VTE, including patient characteristics, procedure type, and operative time, were analyzed by univariable analysis using logistic regression. Risk factors showing a significant association with VTE (P < 0.1) were entered into a hierarchical logistic regression model, accounting for clustering of patients within hospitals. Significant risk factors (P < 0.05) were kept in the model.
Because predictive models perform better on the data from which they were derived than on new data, 17, 18 we performed bootstrap resampling to obtain bias-corrected confidence intervals (CIs), thereby providing a more honest estimate of model performance. We chose this method of internal validation because bootstrap resampling techniques have been shown to produce stable and nearly unbiased estimates of predictive accuracy, with better efficiency than other methods of internal validation, such as split-sample modeling. 18 One hundred random bootstrap samples with replacement, and of the same size as the original sample, were drawn from the original dataset consisting of all patients. With replacement means that at each step in the selection process, every individual from the original sample is again eligible to be selected, whether or not he/she has already been selected. Thus, in each bootstrap sample, an individual may be represented once, more than once, or not at all. Separate generalized linear mixed models were developed on the basis of each bootstrap run. The standard error estimates were averaged across the 100 bootstrap samples to obtain bias-corrected CIs for each regression coefficient.
Using the coefficients obtained from the model, we developed a risk calculator to estimate an individual patient's probability of developing a VTE complication after bariatric surgery. Each risk factor was used as a dichotomous variable. The risk calculator works by combining an individual patient's values for each risk factor with the coefficients from the model into a regression equation that yields the odds of developing a serious complication. From the odds, the probability of developing a complication is obtained by the following transformation: probability (%) = 100 × odds/(1 + odds). The regression equation takes the form:
In this equation, EXP is equivalent to e x , where "e" is the base of the natural logarithm (2.718); β 0 is the model intercept; β 1 through β k represent the coefficients from the model corresponding to individual predictors; X 1 through X k represent an individual patient's data for each risk factor. For items with a yes/no response, "yes" = 1 and "no" = 0. For procedure type, the reference group was adjustable gastric band (X = 0). For the remaining procedures, X is set at 1 for the patient's specific procedure, whereas X is set to 0 for all other procedures.
Notably, we did not include postoperative complications in the model. Although serious complications, such as anastomotic leak, are likely to be significant risk factors for VTE, they cannot be used to predict risk before surgery and thus were excluded from the analysis. We did include operative time in the risk calculator, albeit with the understanding it would need to be estimated preoperatively. In the event that the operative time was different than anticipated, the patient's VTE risk would need to be recalculated after surgery.
All analyses were performed using SAS version 9.2 (SAS Institute Inc, Cary, NC). The study protocol was approved by the institutional review boards of the University of Michigan and all participating hospitals. The requirement for informed consent was waived.
RESULTS
During the study period, 27,818 patients underwent bariatric surgery at 32 hospitals throughout the state of Michigan. Of these patients, 15,941 underwent gastric bypass (1117 with an open approach), 8595 laparoscopic adjustable gastric band (LAGB), 2936 sleeve gastrectomy, and 346 biliopancreatic diversion with duodenal switch. Overall, the majority of procedures (95%) were performed laparoscopically and conversion rates were low (0.8%), although with duodenal switch, 67% were done using an open approach. Patient characteristics, comorbidities, and perioperative process measures are detailed in Table 1 . Of the bariatric surgery patients, 78% were women, with a mean age of 46 years and mean BMI of 48. Nearly all patients (98%) were treated with an anticoagulant (unfractionated heparin or low molecular weight heparin) in the perioperative period.
Overall, 93 patients (0.33%) experienced a VTE complication (58 DVT, 51 PE, 16 both DVT and PE). There were 8 associated deaths, yielding a case fatality rate of 8.6% and accounting for onethird of all deaths in the registry. Significant risk factors for VTE on multivariable analysis are detailed in Table 2 Finally, an operative time of more than 3 hours was also a significant predictor of VTE (OR 1.86, CI 1.07-3.24).
On the basis of the coefficients listed in Table 2 , we developed a preoperative risk calculator for VTE in patients undergoing bariatric surgery. The regression equation for the model is depicted in Table  2 . Using this predictive model, we found that 96.7% of patients had a predicted risk of VTE of less than 1%. The predicted VTE risk was between 1% and 4% in 3.2% of patients, and greater than 4% in 0.16% of patients. A user-friendly version of the risk calculator can be found on the MBSC Web site at https://www.michiganbsc.org/vte predictor1.asp. As an example of how to use the risk calculator, take a 60-year-old male patient with a BMI of 55 kg/m 2 , and no VTE history, who is scheduled for laparoscopic gastric bypass and whose operative time is expected to be less than 3 hours. His estimated VTE risk would be 0.87%. 
DISCUSSION
In this prospective, population-based study of morbidly obese patients undergoing bariatric surgery, the overall rate of VTE was quite low at 0.33%, with nearly 97% of patients having less than a 1% risk of VTE. We identified several risk factors, which were associated with VTE, the most significant of which was procedure type. The probability of VTE was highest for patients undergoing the duodenal switch procedure, followed by open gastric bypass, laparoscopic gastric bypass, sleeve gastrectomy, and adjustable gastric band. Other factors which were significant on multivariable analysis included previous history of VTE, male gender, operative time more than 3 hours, BMI category, and age category.
Our results are consistent with previous work examining risk factors for VTE after bariatric surgery. Previous history of VTE and BMI were significant predictors of VTE in several large series of bariatric surgery patients. 2, 4, [8] [9] [10] Age, male gender, and prolonged operative time have also been reported as risk factors for VTE in this population. 1, 4 In addition, all of these risk factors have been identified as predictors of VTE in nonbariatric surgery also, including orthopedic, gynecologic, urologic and other major abdominal procedures. 7, [19] [20] [21] [22] [23] [24] Furthermore, several of these factors, including previous history of VTE, BMI, and age have also been shown to contribute to VTE risk in nonsurgical patients. [25] [26] [27] There is little data on variability in VTE risk among the different bariatric surgery procedures. In a prospective study of 4776 patients undergoing LAGB or gastric bypass, VTE rates were 0.3% in patients undergoing LAGB, 0.4% in those undergoing laparoscopic gastric bypass, and 1.1% in those undergoing open gastric bypass (P = 0.05). 28 Several other studies have compared gastric bypass to LAGB and found no significant difference in VTE rates. [29] [30] [31] [32] However, these were largely single center studies (most with <1000 patients) and were underpowered to detect differences in VTE rates, given the Use patient values and coefficients from the model to calculate odds of developing a serious complication using the equation given later. The probability (%) = odds/(1 + odds). The notation EXP is equivalent to e x , where "e" is the base of the natural logarithm (2.718). For items with a yes/no response, "yes" = 1 and "no" = 0. For procedure type, the reference group is adjustable gastric band. It is not surprising that LAGB was associated with a lower risk for VTE in this study. These procedures have substantially shorter operative times (mean 61 minutes in our study vs 111 minutes for all other procedures) and overall significantly lower rates of serious complications (1.0% vs 3.1% for all other procedures). By contrast, the markedly elevated VTE risk found with open gastric bypass and duodenal switch should be interpreted cautiously. With regard to gastric bypass, it is reasonable to assume that for some portion of the procedures, the open approach was chosen because of other factors (eg, multiple previous operations, large ventral hernia) that precluded a laparoscopic approach. In fact, 10% of open gastric bypass cases included a ventral hernia repair compared to 1% with all other cases. The added complexity of these procedures may have contributed to the added VTE risk. With regard to duodenal switch, the overall number of cases was low. Furthermore, more than two-thirds of these procedures were done open, 7% were associated with a concurrent hernia repair, and the rate of anastomotic leak was nearly 5 times that of all other procedures. All of these factors may have contributed to the substantially higher rate of VTE with the duodenal switch procedure. It is likely that the VTE risk associated with duodenal switch would be lower in settings where these operations were routinely performed laparoscopically.
Ours is the first population-based study to develop a preoperative risk calculator for identifying patients at especially high risk for VTE who would potentially benefit from more aggressive VTE prophylaxis, such as extended postdischarge thromboprophylaxis or postoperative therapeutic anticoagulation. Using a similar strategy of risk stratification, Caruana and colleagues 33 recently reported success in reducing PE rates after bariatric surgery. The authors developed a PE risk score using commonly accepted risk factors. They then stratified patients into 3 risk groups on the basis of their score and used this to determine the level of VTE prophylaxis. Using this strategy, the authors demonstrated a reduction in rates of PE from 1% in a historical control group of 1341 open gastric bypass patients to 0.36% in a prospectively studied group of 1652 patients undergoing mostly open gastric bypass. The added benefit of our risk calculator is that the risk score is determined using empiric data and can be updated as additional data accumulates.
It is important to note that other factors are associated with substantially increased risk for VTE. Patients with underlying hypercoaguable disorders, such as Factor V Leiden and Protein C or S deficiency, are at high risk for VTE and should be considered for more aggressive thromboprophylaxis. Given the rarity of these conditions, however, they were not included in the patient profiles for data collection in the MBSC. In addition, certain serious complications, such as anastomotic leaks, have been associated with subsequent development of VTE and merit more aggressive VTE prophylaxis. Indeed, when anastomotic leak was included in the regression model for this study, it proved to be a highly significant predictor of VTE, with an OR of 8.84 (CI 3.59-21.73). We did not include anastomotic leak in our risk calculator, however, as it would not be helpful in determining risk before surgery. Furthermore, a substantial number of anastomotic leaks occur after hospital discharge and would therefore not be helpful in determining the need for extended postdischarge chemoprophylaxis.
Our study does have several limitations. First, the registry does not capture events occurring beyond 30 days after the procedure, which could lead to underreporting of the VTE rate. However, a substantial number of VTE events are known to occur after hospital discharge, whereas most occur within 30 days of the procedure. risk prediction model may not perform as well in a different population of patients undergoing bariatric surgery. Further studies are needed to validate this prediction model in an independent population of bariatric surgery patients.
The aim of the MBSC is to reduce performance variation among hospitals performing bariatric surgery in the state of Michigan and improve patient outcomes. With regard to VTE prevention, the next step will be to develop evidence-based standardized practices, with input from leading experts in VTE prophylaxis, and a structured approach to achieving clinical consensus among providers in the MBSC. Using a standardized approach to VTE prophylaxis, informed by risk-prediction models from the MBSC clinical registry data, we hope to minimize the risks of postoperative VTE, while avoiding the negative effects of prophylaxis, such as bleeding and complications related to vena cava filter placement. 34 The structure of the MBSC, and its clear focus on collaborative quality improvement, will allow for a robust assessment of the effects of such a standardized approach.
